Clinical Trial Update: Topical Diclofenac and Topical DFMO Chemoprevention Trial in Subjects With a History of Skin Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating topical diclofenac and topical DFMO for chemoprevention in people with a history of non-melanoma skin cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-melanoma Skin Cancer

Drugs mentioned

• Topical DFMO (difluoromethylornithine)
• Topical diclofenac (diclofenac topical)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Non-melanoma Skin Cancer | Phase 2 | Status: COMPLETED